Abstract
Polypharmacy is increasing, seemingly inexorably, and inevitably the associated difficulties for individual patients of coping with multiple medicines rise with it. Using medicines is one aspect of the burden associated with living with a chronic condition. It is becoming increasingly important to measure this burden particularly that relating to multiple long-term medicines. Pharmacists and other health professionals provide a myriad of services designed to optimise medicines use, ostensibly aiming to help and support patients, but in reality many such services focus on the medicines, and seek to improve adherence rather than reducing the burden for the patient. We believe that the patient perspective and experience of medicines use is fundamental to medicines optimisation and have developed an instrument which begins to quantify these experiences. The instrument, the Living with Medicines Questionnaire, was generated using qualitative findings with patients, to reflect their perspective. Further development is ongoing, involving researchers in multiple countries.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Salisbury C, Johnson L, Purgy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care. A retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.
Moynihan R, Doust J, Henry D. Preventing over-diagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.
Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28:159–72.
Duerden M, Avery AJ, Payne R. Polypharmacy and medicines optimisation—making it safe and sound. London: The King’s Fund; 2013.
Gnjidic D, Le Couter DG, Pearson S-A, McLachlan AJ, Viney R, Hilmer SN, Blyth FM, Joshy G, Banks E. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;13:115. doi:10.1186/1471-2458-13-115.
Morgan T, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes JA. National census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196:50–3.
Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated review. J Gerontol Nurs. 2005;31:4–11.
May M, Montori V, Mair F. We need minimally disruptive medicine. BMJ. 2009;339:485–7.
Sav A, Kendall E, Mc Millan SS, Kelly F, Whitty JA, King MA, Wheeler AJ. ‘You say treatment, I say hard work’: treatment burden among people with chronic illness and their carers in Australia. Health Soc Care Commun. 2013;21(6):665–74.
Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.
Reeve E, Weiss MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriat Soc. 2013;61:1508–14.
Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011;9:95.
Morecroft CW, Cantrill J, Tully MP. Patients’ evaluation of the appropriateness of their hypertension management—a qualitative study. Res Soc Admin Pharm. 2006;2:186–211.
Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. I don’t know how many of these [medicines] are necessary. A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2008;74:135–41.
Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.
Pharmaceutical Services Negotiating Committee. Medicines Use Review service. http://www.psnc.org.uk/pages/mur.html. Accessed 07 Feb 2014.
Australian Government Department of Human Services. Home medicines review service. https://www.medicareaustralia.gov.au/provider/pbs/fourth-agreement/hmr.jsp. Accessed 7 Feb 2014.
American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice. 2008. http://www.pharmacist.com/sites/default/files/files/core_elements_of_an_mtm_practice.pdf. Accessed 7 Feb 2014.
Royal Pharmaceutical Society. Medicines optimisation: helping patients make the most of medicines. London: RPS; 2013. http://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf. Accessed 7 Feb 2014.
Krska J, Rowe PH. Outcome measures: a sensitive approach. Int J Pharm Pract. 2010;18:125–7.
Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.
Eton DT, Elraiyah TA, Yost KJ, Ridgeway LJ, Johnson A, Eggington JS, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.
Blalock SJ, Patel RA. Drug therapy concerns questionnaire: Initial development and refinement. J Am Pharm Assoc. 2005;45:160–9.
Rowe PH, Krska J. Satisfaction with medicines: the views of elderly patients. Int J Pharm Pract. 2008;16(suppl 1):A3.
Krska J, Morecroft CW, Poole H, Rowe PH. A novel instrument to measure medicines-related quality of life. Int J Clin Pharm. 2013;35:488.
Funding
Preliminary work on the instrument was funded by Liverpool John Moores University.
Conflicts of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krska, J., Morecroft, C.W., Rowe, P.H. et al. Measuring the impact of long-term medicines use from the patient perspective. Int J Clin Pharm 36, 675–678 (2014). https://doi.org/10.1007/s11096-014-9970-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-014-9970-5